bovnews8h
Why Is Cassava Sciences Inc (SAVA) Stock Lagging Behind -67.39% from Its 50-Day SMA?
H.C. Wainwright has recently reduced Cassava Sciences Inc (SAVA) stock to Neutral rating, as announced on November 26, 2024, according to Finviz. Earlier, on October 8, 2024, H.C. Wainwright had ...
H.C. Wainwright ups Akero target after ‘ground-breaking’ data
H.C. Wainwright raised the firm’s price target on Akero Therapeutics (AKRO) to $72 from $50 and keeps a Buy rating on the shares after the ...
bovnews11h
What’s Driving Humacyte Inc (HUMA) Stock’s -0.65% Plunge Over the Past Month?
Humacyte Inc (HUMA) stock saw a modest uptick, ending the day at $4.61 which represents a slight increase of $0.02 or 0.44% from the prior close of $4.59. The stock opened at $4.59 and touched a low ...
H.C. Wainwright Sticks to Their Hold Rating for Agenus (AGEN)
In a report released today, Emily Bodnar from H.C. Wainwright maintained a Hold rating on Agenus (AGEN – Research Report). The company’s shares ...
H.C. Wainwright maintains $30 target on Voyager Therapeutics stock
The confidence in Voyager Therapeutics (NASDAQ:VYGR)' stock is further supported by the company's strategic collaborations, ...
H.C. Wainwright maintains $100 target, Buy on Immunocore stock
In conclusion, H.C. Wainwright's analyst remains optimistic about Immunocore's prospects, underpinned by the potential of its diverse pipeline and upcoming clinical milestones. With a market ...
LSI Industries (NASDAQ:LYTS) Price Target Raised to $26.00
LSI Industries (NASDAQ:LYTS – Free Report) had its target price raised by Canaccord Genuity Group from $22.00 to $26.00 in a research note published on Friday,Benzinga reports. The brokerage currently ...
Dyne Therapeutics’ (DYN) Buy Rating Reiterated at Guggenheim
Guggenheim reissued their buy rating on shares of Dyne Therapeutics (NASDAQ:DYN – Free Report) in a report released on Friday,Benzinga reports. Other equities analysts have also recently issued ...